Benzinga | Nov 2, 2021 04:49PM EDT

Amedisys Q3 Adj. EPS $1.53 Beats $1.36 Estimate, Sales $553.50M Miss $568.37M Estimate

Amedisys (NASDAQ:AMED) reported quarterly earnings of $1.53 per share which beat the analyst consensus estimate of $1.36 by 12.5 percent. This is a 31.7 percent decrease over earnings of $2.24 per share from the same period last year. The company reported quarterly sales of $553.50 million which missed the analyst consensus estimate of $568.37 million by 2.62 percent. This is a 1.73 percent increase over sales of $544.07 million the same period last year.